Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Irani

Showing results (41-50 of 112) with videos related to

Pageof 12
Sort By:
The Lancet. Oncology|December 8, 2009
Efficacy of venlafaxine, medroxyprogesterone acetate, and cyproterone acetate for the treatment of vasomotor hot flushes in men taking gonadotropin-releasing hormone analogues for prostate cancer: a double-blind, randomised trialJacques Irani, Laurent Salomon, Rostand Oba, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|January 28, 2003
[Hyperbaric oxygen therapy and radiation-induced hemorrhagic cystitis]Christophe Pires, Jacques Irani, Frédéric Ouaki, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|March 6, 2004
[Management of bladder cancer associated with prostate cancer]Jean-Louis Bonnal, Jacques Irani, Marc Maidenberg, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|December 3, 2003
[Partial infarction of the kidney caused by spontaneous idiopathic dissection of the renal artery]Laurent Dahmani, François-Joseph Murat, Frédéric Ouaki, et al.
The Journal of Urology|September 21, 2010
Expression of estrogen related proteins in hormone refractory prostate cancer: association with tumor progressionOlivier Celhay, Mokrane Yacoub, Jacques Irani, et al.
International Journal of Radiation Oncology, Biology, Physics|April 27, 2016
DNA-PKcs Expression Is a Predictor of Biochemical Recurrence After Permanent Iodine 125 Interstitial Brachytherapy for Prostate CancerSarah Molina, Stéphane Guerif, Alexandre Garcia, et al.
BJU International|January 18, 2014
Is intermittent androgen-deprivation therapy beneficial for patients with advanced prostate cancer?Johannes M Wolff, Per-Anders Abrahamsson, Jacques Irani, et al.
The Prostate|September 2, 2014
ERG expression in prostate cancer: the prognostic paradoxMichael Taris, Jacques Irani, Pascal Blanchet, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|December 5, 2002
[Consequences of intravesical obstruction on detrusor muscle energy metabolism]Laurent Dahmani, Franck Bruyère, Frédéric Ouaki, et al.
BJU International|February 28, 2007
Fluctuating prostate-specific antigen levels in patients with initial negative biopsy: should we be reassured?Olivier Celhay, Alexandre de la Taille, Laurent Salomon, et al.
Pageof 12

Showing results (41-50 of 112) with videos related to

Sort By:
Pageof 12
The Lancet. Oncology|December 8, 2009
Efficacy of venlafaxine, medroxyprogesterone acetate, and cyproterone acetate for the treatment of vasomotor hot flushes in men taking gonadotropin-releasing hormone analogues for prostate cancer: a double-blind, randomised trialJacques Irani, Laurent Salomon, Rostand Oba, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|January 28, 2003
[Hyperbaric oxygen therapy and radiation-induced hemorrhagic cystitis]Christophe Pires, Jacques Irani, Frédéric Ouaki, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|March 6, 2004
[Management of bladder cancer associated with prostate cancer]Jean-Louis Bonnal, Jacques Irani, Marc Maidenberg, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|December 3, 2003
[Partial infarction of the kidney caused by spontaneous idiopathic dissection of the renal artery]Laurent Dahmani, François-Joseph Murat, Frédéric Ouaki, et al.
The Journal of Urology|September 21, 2010
Expression of estrogen related proteins in hormone refractory prostate cancer: association with tumor progressionOlivier Celhay, Mokrane Yacoub, Jacques Irani, et al.
International Journal of Radiation Oncology, Biology, Physics|April 27, 2016
DNA-PKcs Expression Is a Predictor of Biochemical Recurrence After Permanent Iodine 125 Interstitial Brachytherapy for Prostate CancerSarah Molina, Stéphane Guerif, Alexandre Garcia, et al.
BJU International|January 18, 2014
Is intermittent androgen-deprivation therapy beneficial for patients with advanced prostate cancer?Johannes M Wolff, Per-Anders Abrahamsson, Jacques Irani, et al.
The Prostate|September 2, 2014
ERG expression in prostate cancer: the prognostic paradoxMichael Taris, Jacques Irani, Pascal Blanchet, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|December 5, 2002
[Consequences of intravesical obstruction on detrusor muscle energy metabolism]Laurent Dahmani, Franck Bruyère, Frédéric Ouaki, et al.
BJU International|February 28, 2007
Fluctuating prostate-specific antigen levels in patients with initial negative biopsy: should we be reassured?Olivier Celhay, Alexandre de la Taille, Laurent Salomon, et al.
Pageof 12